Interactome overlap between schizophrenia and cognition E Koch, B Rosenthal, A Lundquist, CH Chen, K Kauppi Schizophrenia Research 222, 167-174, 2020 | 17 | 2020 |
Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individuals E Koch, L Nyberg, A Lundquist, S Pudas, R Adolfsson, K Kauppi Translational Psychiatry 11 (1), 520, 2021 | 13 | 2021 |
The relationship between cannabis use, schizophrenia, and bipolar disorder: a genetically informed study W Cheng, N Parker, N Karadag, E Koch, G Hindley, R Icick, A Shadrin, ... The Lancet Psychiatry 10 (6), 441-451, 2023 | 9 | 2023 |
Drug repurposing candidates to treat core symptoms in autism spectrum disorder E Koch, D Demontis Frontiers in Pharmacology 13, 995439, 2022 | 7 | 2022 |
Polygenic overlap with body-mass index improves prediction of treatment-resistant schizophrenia KS O'Connell, E Koch, HÇ Lenk, IA Akkouh, G Hindley, P Jaholkowski, ... Psychiatry research 325, 115217, 2023 | 5 | 2023 |
Polygenic risk for schizophrenia has sex-specific effects on brain activity during memory processing in healthy individuals E Koch, L Nyberg, A Lundquist, K Kauppi Genes 13 (3), 412, 2022 | 3 | 2022 |
Longitudinal effects of using and discontinuing central nervous system medications on cognitive functioning E Koch, K Johnell, K Kauppi Pharmacoepidemiology and Drug Safety 32 (4), 446-454, 2023 | 2 | 2023 |
Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging A Supiyev, R Karlsson, Y Wang, E Koch, S Hägg, K Kauppi Neurobiology of Aging 126, 103-112, 2023 | 1 | 2023 |
APOE ɛ4, but not polygenic Alzheimer’s disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals S Håglin, E Koch, F Schäfer Hackenhaar, L Nyberg, K Kauppi Scientific Reports 13 (1), 8433, 2023 | 1 | 2023 |
Candidates for drug repurposing to address the cognitive symptoms in schizophrenia E Koch, K Kauppi, CH Chen Progress in Neuro-Psychopharmacology and Biological Psychiatry 120, 110637, 2023 | 1 | 2023 |
400. Polygenic Architecture of Metabolic Markers Reveals Distinct Patterns of Overlap With Psychiatric Disorders D van der Meer, Z Rahman, A Ottas, P Parekh, G Kutrolli, I Sønderby, ... Biological Psychiatry 95 (10), S263-S264, 2024 | | 2024 |
Shared genetic loci between clozapine metabolism and granulocyte counts E Koch, N Parker, SK Lock, RL Smith, AA Shadrin, O Frei, AM Dale, ... | | 2024 |
Polygenic liability for antipsychotic dosage and polypharmacy-a real-world registry and biobank study E Koch, A Kämpe, M Alver, S Sigurðarson, G Einarsson, J Partanen, ... Neuropsychopharmacology, 1-7, 2024 | | 2024 |
How real-world data can facilitate the development of precision medicine treatment in psychiatry E Koch, AF Pardiñas, KS O’Connell, P Selvaggi, JC Collados, A Babic, ... Biological Psychiatry, 2024 | | 2024 |
NOVEL LOCI FOR ANTIDEPRESSANT RESPONSE IDENTIFIED FROM GENOME-WIDE ASSOCIATION STUDIES AND MULTI-TRAIT META-ANALYSES E Koch, K Krebs, T Jürgenson, L Milani, K O'Connell, O Andreassen European Neuropsychopharmacology 75, S53, 2023 | | 2023 |
Novel genomic risk loci and improved prediction for treatment-resistant schizophrenia are revealed by leveraging polygenic overlap with body-mass index K O'Connell, E Koch, H Lenk, I Akkouh, G Hindley, P Jaholkowski, ... | | 2022 |
APOE ɛ4, but not polygenic AD risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals S Håglin, E Koch, FS Hackenhaar, L Nyberg, K Kauppi | | 2022 |
The genetics of schizophrenia: sex, drugs, and cognition E Koch Umeå universitet, 2022 | | 2022 |
Longitudinal effects of using and discontinuing CNS medications on cognitive functioning E Koch, K Johnell, K Kauppi bioRxiv, 2021.09. 13.460082, 2021 | | 2021 |
O11. 4. INTERACTOME OVERLAP BETWEEN SCHIZOPHRENIA AND COGNITION E Koch, B Rosenthale, A Lundquist, CH Chen, K Kauppi Schizophrenia Bulletin 46 (Suppl 1), S28, 2020 | | 2020 |